Vincent Michael Lawton
CIK: 0002123870
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ADXN
Addex Therapeutics Ltd.
Director
Discretionary Trading P&L
Holdings
About Lawton Vincent Michael
Lawton Vincent Michael (SEC CIK 0002123870) files insider reports with the SEC as Director of Addex Therapeutics Ltd. (ADXN).
Signal8 holds 2 ownership filings by Lawton Vincent Michael (1 Form 3, 1 Form 4), filed between Mar 25, 2026 and Sep 4, 2026. Those filings report 2 transactions, the latest on Sep 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lawton Vincent Michael's filings is in GENEVA.
Recent filings by Lawton Vincent Michael
Other insiders filing for Addex Therapeutics Ltd. (ADXN)
- Teyssedou Lenaic Nathanael, PRINCIPAL ACCOUNTING OFFICER
- Kalinichev Mikhail, HEAD OF TRANSLATIONAL SCIENCE
- Nunn Jason Raleigh, Director
- Mills Roger, CHIEF MEDICAL OFFICER
- Manke Isaac, Director
- Hill Raymond George, Director